Although the underlying mechanism(s) remains to be elucidated, we found that the significant decrease of PPAR-gamma and CIDEA mRNA levels in the livers of CCDC3 TG mice compared to that in control mice must account for the this anti-steatosis phenotype (Fig. 6g). The gene discussed is PPARG; the disease is steatosis.